chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feel pain on the left side which was the injection side of his body; started to get the swollen lumps on that side of the body; Not feeling the best the day on; This is a spontaneous report from a contactable consumer received via Pfizer-sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: unspecified), via an unspecified route of administration on 17May2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: unspecified), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. Reporter stated that she and her husband received the second dose of the COVID vaccine on Monday (17May2021), stated that her husband was not feeling the best the day on. On the next day (18May2021) he started to feel fine and on last night he started to feel pain on the left side which was the injection side of his body and then he started to get the swollen lumps on that side of the body. The clinical outcome was unknown for all events except for event, not feeling the best the day on was recovered on 18May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 30-MAY-2017, the patient was inadvertently vaccinated with an expired dose of VARIVAX lot # L018002, expiration date 19-MAY-2017 (strength, dose and route were unknown) for prophylaxis. It was reported that the vaccine was used with an sterile diluent with lot and expiration date unknown. There were no adverse effects reported.    Additional information has been requested.
Patient noticed facial paralysis starting on 10/8/2018 with facial droop, slurred speech, eye drooping.
tired; This is a spontaneous report from a contactable consumer (Patient).   A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation solution for injection; Lot number was not reported), via an unspecified route of administration, on an unspecified date, as single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient was tired and thought it was due to getting his COVID-19 vaccine. The outcome of the event was unknown.  Information about lot/Batch number has been requested.
Received H1N1 vaccine. Stood up and told mom he had stomach ache. He fell back and postured for 5 sec. Became conscious and knew who and where he was, egg-sized knot on back of head at occipital. 911 was called and EMT'S arrived and assessed-transported to hospital.
From faxed correspondence received on 8/15/02, it was reported that a 64 year old female received Td vaccine on 8/1/02. Patient developed a 10cmx12cm warm and erythematous area in left deltoid. Tenderness disappeared two days after vaccination. Patient was given Keflex 500mg orally four times a day for cellulitis.
FOGGY HEAD; DIZZINESS; HEADACHE; MILD NUMBNESS; EXTREME FATIGUE; MUSCLE PAIN; SLEEPINESS; This spontaneous report received from a patient concerned a 52 year old. The patient's height, and weight were not reported. The patient's past medical history included stroke, and artery dissection, and concurrent conditions included non smoker, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested, Concomitant medications included acetylsalicylic acid. On 10-APR-2021, the subject experienced mild numbness. On 10-APR-2021, the subject experienced sleepiness. On 10-APR-2021, the subject experienced extreme fatigue. On 10-APR-2021, the subject experienced muscle pain. On 11-APR-2021, the subject experienced foggy head. On 11-APR-2021, the subject experienced dizziness. On 11-APR-2021, the subject experienced headache. Laboratory data (dates unspecified) included: COVID-19 virus test negative (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from muscle pain, and mild numbness, had not recovered from headache, foggy head, sleepiness, and dizziness, and the outcome of extreme fatigue was not reported. This report was non-serious.
Body aches day after vaccine.  Numbness in 5th finger 1-2 days after vaccine.  Redness, swelling, tenderness and warmth at the site of infection. Rrescribed antibiotics for possible cellulitis.
Migraine  headaches, dizziness, nausea, weakness, numbness, pins and needles, palpitations, ringing in ears, clamminess, hot flashes
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered 2 days beyond use date) and PRODUCT STORAGE ERROR (Vaccine administered 2 days after beyond use date) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059A22A) for COVID-19 prophylaxis. Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN for an unknown indication. On 28-Jun-2022 at 8:00 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 28-Jun-2022 at 8:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered 2 days beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered 2 days after beyond use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered 2 days beyond use date) and PRODUCT STORAGE ERROR (Vaccine administered 2 days after beyond use date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient born with twins. Number of doses/vials was reported as 7. On 26-May-2022, the vial was initially stored in the refrigerator. Vaccine was administered from 26-Jun-2022 to 4-Jul-2022. Vial did not undergo any temperature excursions. No treatment drug were reported.
The first dose, I was really sick with my whole body shaking. I was sick for a couple days. I did not take anything for my symptoms, I prayed. The second dose, I didn't have an adverse reaction but several months later I had severe pain. I have severe nerve damage from my neck down to my feet. I had pain at the injection side that subsided. I have memory loss. I put something down and could not remember where I put it. I forget what I'm talking about when talking to family/friends.
1 of 5 pts who was vaxed from the same vial devel a high fever x 5 days following vax;
I received my 3rd dose of the Pfizer vaccine on 12/04/2021. My adverse event started on 11/18/2022 around 4:00PM. I have chills and fever. My mouth and jaw was swollen. This was from bacterial infection since my wisdom tooth was growing. I've never been sick like this before. I felt like if I slept I won't be able to wake up again. I had mouth sores. It was bruising all over my body. This continued from 11/18/2022-11/23/2022. On Saturday 11/19/2022 I went to the ER. They prescribed me with oral steroids (magic mouthwash). I don't now the exact name. I tried taking it for 3 days. I stopped using it because I've noticed it wasn't helping. I went to the dentist on 11/21/2022. They prescribed me an anti viral mouthwash along with antibiotics. They recommended me to remove my wisdom tooth out. My teeth was very sensitive for 1 day. I couldn't eat anything for 1 week. It was very painful.
Have been having an ongoing headache since receiving the shot along with nausea. Have tried taking Tylenol but doesn?t work.
Possible chickenpox. Pt with widespread rash, with some tiny blisters. C/o itching. Rash began at site of VARIVAX injection. Pt to take ZYRTEC and BENADRYL. Acyclovir 400 mg, 4 x daily scripted.
Chills, body aches, headache, lethargic for 24 hrs after vaccine
Periods got heavier ,longer , clots in the flow; Achy; Really bad headache; Felt like she had been hit by tractor trailer; Chills; Flu like symptoms; Coughing; Arm hurt really bad; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt like she had been hit by tractor trailer), INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Coughing), PAIN IN EXTREMITY (Arm hurt really bad) and MENSTRUAL DISORDER (Periods got heavier ,longer , clots in the flow) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 031L20A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sciatica (Patient takes cortisone injections for her back problem/sciatica. Patient is immunocompromised secondary to receiving the cortisone injections), Morbid obesity, Blood pressure (Patient has high blood pressure), Asthma and Liver disorder. Concomitant products included METOPROLOL SUCCINATE (TOPROL) for Allergy, CORTISONE for Sciatica, LOSARTAN and HYDROCHLOROTHIAZIDE for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION COMPLICATION (Felt like she had been hit by tractor trailer), INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Coughing), PAIN IN EXTREMITY (Arm hurt really bad), CHILLS (Chills) and HEADACHE (Really bad headache). On 17-Feb-2021, the patient experienced MYALGIA (Achy). In March 2021, the patient experienced MENSTRUAL DISORDER (Periods got heavier ,longer , clots in the flow). At the time of the report, VACCINATION COMPLICATION (Felt like she had been hit by tractor trailer), INFLUENZA LIKE ILLNESS (Flu like symptoms), COUGH (Coughing), PAIN IN EXTREMITY (Arm hurt really bad), MENSTRUAL DISORDER (Periods got heavier ,longer , clots in the flow), CHILLS (Chills), MYALGIA (Achy) and HEADACHE (Really bad headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Liver function test: increased (High) Liver panel drawn shows elevated liver enzymes. Liver panel drawn previously in December was.         Patient says she is trying to decide about taking the 3rd dose as she is at risk. treatment information was not provided   This case was linked to MOD-2021-305846 (Patient Link).
Information has been received from a licensed practical nurse concerning a 22-month-old white male with a history of gastroesophageal reflux as an infant (no treatment now) and with no drug reactions/allergies.  It was also noted that the child was underweight (per the physician), noted to be in the less than third percentile for weight while in the fifth percentile for height.  On 03-MAR-2005, the patient was vaccinated SC in the left thigh with a first 0.5 ml dose of varicella virus vaccine live (0984P).  There was no illness at the time of vaccination.  There was no concomitant medication.  On 15-DEC-2005 the patient experienced a diffuse rash over his trunk, back, abdomen and lower extremities.  He was also noted to have a fever for 2 days.  The physician ordered only symptomatic treatment if/as needed, including fluids, rest and acetaminophen as needed.  The physician does not know the number or type lesions or how high the child's temperature was.  At the time of the report, the patient was comfortable, without other complications, and was noted to be recovering.  There was no product quality complaint.  Follow up information indicated that on 15-DEC-2005 the patient developed chickenpox.  The patient has since recovered.  There were no relevant diagnostic tests or laboratory data.  No additional information is expected.
Vaccine administration error. Covid vaccine given ahead of recommended minimal interval at 14 days.  Medical director and patient's mother notified of administration error. No current indication to repeat vaccination series or administer additional dose.
Large red mark at injection site very sore for 3 days, hot to touch approximately 10cm. Advised: ice and Benadryl.
no immediate reaction (received on a Thursday). Had a sudden 'itch attack' on following Sunday.  Hives/rash started around bra line Monday and continually progressed to chest & neck, reaching jaw line.  On 4/29 I got a RX for 50mg Prednisone x 5 days with provided a small amt of relief. By 5/6,  there was sign of rash on back of upper legs. VERY INTENSE ITCHING.  Trying everything OTC with no relief,  taking 50 mg benadryl at night to sleep (only relief I could get) , I finally went to an urgent care  and got a Dexamethazone shot. It helped some but not enough. Rash continued to travel to armpits, down both arms and down stomach to pants line and around to my back.  I went to Kaiser Urgent care on May 10  where they did extensive blood work and sent pics & result to dermatology. Conclusion: (Physicians note to me) "Just wanted to let you know that dermatology has viewed the photos of your rash and feel you are having a reaction to a medication , supplement or a viral infection.  They recommended the dose of cetirizine (Zyrtec) that we discussed and to add on a topical steroid ointment which I have ordered.  I hope this helps.  " she gave me RX for Trimcinolone Acetonide 0.5%, does not help. Today is May 16 and it seems to be calming however there are some stubborn itchy sites  inside of elbow, inner proximal forearm and stomach.
Administered Infanrix to an adult patient; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 34-year-old male patient who received DTPa (Infanrix) (batch number XG942, expiry date 22nd August 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 14th June 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 14th June 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 15-JUN-2022 Reporter's Comment: LPN (Licensed Practical Nurse) reported that they inadvertently administered Infanrix to an adult patient. Licensed practical nurse inquired how to proceed, any recommendations. The reporter did not consent to follow-up. Additional supportive information: The adult patient received dose of Infanrix vaccine, which led to inappropriate age at vaccine administration.
sz w/deviated gaze, vomiting x 2, tonic-clonic movements x 5-10min, assoc w/ackocyanosis & gen pale-gary color; dx OM & fever 102.2;
Patient began to shake, feel dizzy, and fainted. Had to be rushed to hospital by an ambulance. Couldn't walk, spine was hurting, ringing in ears, and hands were tingling. Heart was racing and was anxious. Tremendously scary event and this vaccine needs to be reviewed.
This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISORDER (Skin did not clear up), COVID-19 (COVID-19) and VACCINATION FAILURE (Vaccination failure) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis and Rheumatoid arthritis. Concurrent medical conditions included Psoriatic arthritis and Rheumatoid arthritis (Moderate to severe rheumatoid arthritis). Concomitant products included INFLUENZA VACCINE for an unknown indication. On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. On 01-Jul-2022, the patient experienced COVID-19 (COVID-19) and VACCINATION FAILURE (Vaccination failure). On an unknown date, the patient experienced SKIN DISORDER (Skin did not clear up). At the time of the report, SKIN DISORDER (Skin did not clear up) and VACCINATION FAILURE (Vaccination failure) outcome was unknown and COVID-19 (COVID-19) was resolving. It was reported that on unknown dates, the patient experienced skin did not clear up. felt overdosed while Humira was taken and COVID-19 hindered the effect of treatment. On 01 Jul 2022, the patient experienced COVID-19 hindered the effect of treatment. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment information was reported. Company Comment: This is a Spontaneous case reported by a consumer, concerning a 50-year-old female patient, with no relevant medical history, who experienced the unexpected and non-serious of COVID-19, which occurred approximately 20 days after the second dose of mRNA-1273 vaccine, which was administered in an appropriate schedule of vaccination. Hence, Vaccination failure was noted. Co-suspect product included non-company product Adalimumab for psoriatic arthritis and rheumatoid arthritis. No information disclosed about diagnostic tests performed or treatments received. At the time of the report, COVID-19 was resolving. The benefit-risk relationship of mRNA-1273 vaccine, is not affected by this report.; Sender's Comments: This is a Spontaneous case reported by a consumer, concerning a 50-year-old female patient, with no relevant medical history, who experienced the unexpected and non-serious of COVID-19, which occurred approximately 20 days after the second dose of mRNA-1273 vaccine, which was administered in an appropriate schedule of vaccination. Hence, Vaccination failure was noted. Co-suspect product included non-company product Adalimumab for psoriatic arthritis and rheumatoid arthritis. No information disclosed about diagnostic tests performed or treatments received. At the time of the report, COVID-19 was resolving. The benefit-risk relationship of mRNA-1273 vaccine, is not affected by this report.
infantile spasms (idiopathic) 1st dx on 5JUN92; eval undertaken & tx initiated by MD;
Patient contracted COVID-19 in September 2020, manifesting primarily with GI symptoms.  She has since completed her vaccination.  A few days ago she started to have respiratory symptoms with coughing, runny nose, and mild shortness of breath.  Also has been tired, with poor appetite.  COVID-19 testing done on 6/29 came back positive.  Tonight she developed more congestion and respiratory distress, as well as hypoxia, and was placed on supplemental O2 at 3 LPM.  Admitted, needing escalating O2, for COVID pneumonia. Also considered superimposed bacterial pneumonia. She was treated with ceftriaxone + azithromycin, dexamethasone, and Remdesivir. Discharged on 7/5.
Develops dizziness on 1/7/2021, intermittent that lasted till 1/8/2021.
Swelling, redness, severe itching at site of vaccine beginning day of vaccine, worsening for 3 days, then improving.
I tested positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of CORONAVIRUS INFECTION (I tested positive for Covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CORONAVIRUS INFECTION (I tested positive for Covid). At the time of the report, CORONAVIRUS INFECTION (I tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Tested positive for covid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.  For mRNA-1273 (COVID 19 Vaccine Moderna), the reporter did not provide any causality assessments.
Moderate pain at injection site immediately after injection.  This spread to involve pain throughout the posterior upper arm for about 6 days before resolving. Did get moderate relief with use of ibuprofen 600 mg PO Q 8 hrs PRN. Received vaccine on 12/23/20 at 6pm.  Woke up at 5am to go to work on 12/24/20 and felt flu-like symptoms with subjective fever (did not measure), joint pain, and diffuse myalgias.  Symptoms progressed over the next three hours and culminated in about half an hour of significant rigors with uncontrolled shivering.  Ibuprofen dose of 600mg orally did help symptoms enough to allow me to finish my shift but I needed two more doses every 8 hours before symptoms resolved in 24 hrs.
Livedo reticularis on bilateral knees; This literature-non-study case was reported in a literature article and describes the occurrence of LIVEDO RETICULARIS (Livedo reticularis on bilateral knees) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   LITERATURE REFERENCE:      No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LIVEDO RETICULARIS (Livedo reticularis on bilateral knees) (seriousness criterion medically significant). At the time of the report, LIVEDO RETICULARIS (Livedo reticularis on bilateral knees) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered LIVEDO RETICULARIS (Livedo reticularis on bilateral knees) to be related.    No concomitant and treatment medication were provided.  Company comment: This literature non-study case concerns a 65-year-old, female patient with no medical history reported, who experienced the unexpected serious (Medically significant) event of Livedo Reticularis (Livedo reticularis on bilateral knees), unspecified days after receiving third dose of mRNA-1273. Outcome of the event is unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This literature non-study case concerns a 65-year-old, female patient with no medical history reported, who experienced the unexpected serious (Medically significant) event of Livedo Reticularis (Livedo reticularis on bilateral knees), unspecified days after receiving third dose of mRNA-1273. Outcome of the event is unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Fever, Chills, Runny Nose, Sore Throat, Headache, Fatigue, Cough, Wheezing
Starting the night of the vaccine I experienced sharp pins and needles on legs and arms. My legs and arms would "fall asleep." Muscles in calves and arms would also feel numb or weak.